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Abstract. In humans, deficient thyroglobulin (Tg, the 
thyroid prohormone) is an important cause of congeni- 
tal hypothyroid goiter; further, homozygous mice ex- 
pressing two cog~cog alleles (linked to the Tg locus) ex- 
hibit the same phenotype. Tg mutations might affect 
multiple different steps in thyroid hormone synthesis; 
however, the microscopic and biochemical phenotype 
tends to involve enlargement of the thyroid ER and ac- 
cumulation of protein bands of Mr <  100. To explore 
further the cell biology of this autosomal recessive ill- 
ness, we have examined the folding and intracellular 
transport of newly synthesized Tg in cog/cog thyroid 
tissue. We find that mutant mice synthesize a full- 
length Tg, which appears to undergo normal N-linked 
glycosylation and glucose trimming. Nevertheless, in 
the mutant, Tg is deficient in the folding that leads to 
homodimerization, and there is a deficiency in the 
quantity of intracellular Tg transported to the distal 
portion of the secretory pathway. Indeed, we find that 
the underlying disorder in cog~cog mice is a thyroid ER 
storage disease, in which a temperature-sensitive Tg 
folding defect, in conjunction with normal ER quality 
control mechanisms, leads to defective Tg export. In re- 
lation to quality control, we find that the physiological 
response in this illness includes the specific induction of 
five molecular chaperones in the thyroid ER. Based on 
the pattern of chaperone binding, different potential 
roles for individual chaperones are suggested in glyco- 
protein folding, retention, and degradation in this ER 
storage disease. 
EFICIENT thyroglobulin (Tg) 1 is estimated to cause 
congenital goiter and hypothyroidism with a prev- 
alence of ~'~1/40,000 humans,  and similar  pathol- 
ogy has been described in numerous animal models (Me- 
deiros-Neto  et  al.,  1993; Medeiros-Neto  and  Stanbury, 
1994). Affected individuals may exhibit a range of pheno- 
types, including hypothyroid growth retardation,  abnor- 
mal central nervous system function, and local compres- 
sion of neck tissues due to an enlarged thyroid mass.  In 
mice, a defective cog gene accounts for the development 
of the same autosomal recessive phenotypes (Beamer et 
al., 1987; Sugisaki et al., 1992); the cog gene is linked to the 
Tg locus (Taylor and Rowe, 1987) and appears to repre- 
sent a mutation in the Tg gene product (Adkison et al., 
1990). 
In humans as well as animal models of this illness, postu- 
lated Tg-related defects have included abnormal mRNA 
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splicing,  translation,  protein  transport,  posttranslational 
modifications, or exocytosis. Interestingly, a frequently de- 
scribed microscopic and biochemical phenotype involves 
distention of the thyroid ER (Michel-Bechet et al., 1969; 
Lissitzky et al., 1975; Mayerhofer et al., 1988) and accumu- 
lation of protein bands (M  r <  100) that are too small  to 
represent full-length  Tg (Basche et al., 1989; Adkison et 
al., 1990; Fogelfeld et al., 1992; Ohyama et al., 1994). 
Because protein iodination leading to thyroid hormone 
synthesis has  been observed on Tg  homodimers  at  the 
end-stage of the secretory pathway (Dunn, 1992; Kuliawat 
and Arvan, 1994), we have been interested in understand- 
ing the process of Tg folding that leads to homodimeriza- 
tion.  Using cultured porcine thyrocytes, we recently have 
established that nascent Tg monomers are highly unfolded 
and susceptible to protein aggregation,  before these mono- 
mers achieve a sufficiently folded conformation to allow 
stable homodimers to form (Kim et al., 1992). It was once 
considered  possible  that  dimerization  might  occur  as  a 
late,  perhaps  postsecretory event (Lissitzky et al.,  1964; 
Seed and Goldberg, 1965; Cavalieri and Searle, 1967; Vec- 
chio et al., 1972; Kondo and Kamiya, 1976). However, it 
has been suggested that because of machinery regulating 
the quality control of protein export, homotypic assembly 
of newly synthesized subunits in the ER may be required 
for normal Tg secretion (Kim and Arvan, 1991). 
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folding and assembly of newly synthesized Tg in cog~cog 
mice. We find that in the mutant, newly synthesized Tg is a 
full-length translation product which appears to undergo 
normal N-linked glycosylation, yet, based on a  tempera- 
ture-sensitive conformational defect, a deficient quantity 
of Tg homodimerizes and exits the ER of thyrocytes. The 
hypothyroidism and  congenital  goiter  in  cog~cog mice 
therefore represents one of a growing family of ER stor- 
age diseases. As a consequence of this perturbation of nor- 
mal thyroid cell biology, we have been able to examine the 
regulation  and  roles  of specific  ER  chaperones  in  the 
physiological setting. 
Materials and Methods 
Animals 
A  breeding pair of cog~cog mice and wild-type littermates were initially 
obtained from the Jackson Laboratories (Bar Harbor, ME). At 2 mo of 
age, the mutant mice were hypothyroid (serum thyroxine  <1.0  p~g/dl) 
compared with the genetically identical background strain (,~4.0 p,g/dl). 
We observed no difference in Tg folding and export between this wild- 
type genetic background and the C-1 strain (not shown); in most experi- 
ments, thyroids from the C-1 strain were used routinely to represent normal 
mice. To eliminate pituitary stimulation of the thyroid, where indicated, 
both sets of animals were treated (12-16 wks) with 1 ixg/ml thyroxine in 
the drinking water. 
Preparation of Thyroid Tissue 
Excised mouse thyroid glands were obtained from euthanized mice and 
analyzed  fresh.  The  thyroids were  trimmed  of connective tissue  and 
chopped into l-ram cubes, each containing only a few follicles (Kim et al., 
1993), or further minced so that some of the follicles  were broken (Fig. 2 B). 
The minced tissue was washed at least three times in ice-cold Dulbecco's 
PBS to remove debris and colloidal contents from follicles injured during 
tissue preparation. 
Antibodies 
Based on the knowledge that the extreme NH2 terminus of mature Tg is 
well conserved between different species (Rawitch et al.,  1984; Dunn et 
al., 1987), a peptide was synthesized representing the first 15 amino acids 
of rat Tg, and this peptide was coupled to the activated carrier protein ac- 
ceptor, KLH (Pierce, Rockford, IL). A polyclonal antibody directed against 
this peptide was raised in chicken, and IgY purified from eggs was gener- 
ated  for use in  subsequent studies. HRP-conjugated anti-chicken-IgY 
(Sigma Chemical Co., St. Louis, MO) was used for immunoblotting with en- 
hanced chemiluminescence  (ECL; Amersham Corp., Arlington Heights, IL). 
Polyclonal  anti-chaperone  antibodies  were  generated  as  follows: 
COOH-terminal synthetic peptides beginning with an introduced cysteine 
(14 residues of routine GRP94, 16 residues of murine BiP, 19 residues of 
rat ERp72 excluding the final 3 residues, 18 residues of rat ER60, 15 resi- 
dues of murine calreticulin, and 19 residues of murine calnexin) were pro- 
tein conjugated and used for immunizing rabbits. The last 18 residues of 
rat ER60 were prepared similarly for immunization in mice. Each of these 
antisera (except that against calnexin, which lacks a KDEL-tail) was first 
passed through a  column covalently bound to the peptide CAVKDEL 
(thereby  removing cross-reacting antibodies); the  unbound portion  of 
these sera were then affinity purified using a similar resin coupled to the 
corresponding peptides listed above. Unpurified sera were suitable for 
Western blotting; affinity purified sera were used for coprecipitation stud- 
ies. Rabbit antisera directed against murine protein disulfide isomerase 
(PDI) (affinity purified against the last 17 residues) and rat ribophorin I 
were obtained from Drs.  T.  Wileman (Pirbright Laboratories, Surrey, 
UK) and G. Kreibich (New York University, NY), respectively. 
Hormones and Other Reagents 
Bovine and ovine thyrotropin (TSH) were obtained from Dr. A.F. Parlow 
via the National Hormone and Pituitary Program. Recombinant endogly- 
cosidase H (endo H) was from New England Biolabs Inc. (Beverly, MA). 
Protease inhibitors, iodoacetamide, tunicamycin, brefeldin A, and dithio- 
threitol were from Sigma Chemical Co., castanospermine was from Boeh- 
ringer Mannheim Biochemicals (Indianapolis, IN), Zysorbin-Protein A 
was from Zymed Labs, Inc. (San Francisco, CA), and Omnisorb-Protein 
G was from Calbiochem Corp. (La Jolla, CA). 
Cell Labeling and Lysis 
For each tissue preparation, samples were incubated for 30 min at 37°C in 
DME lacking methionine and cysteine. The tissue was then labeled for up 
to 30 min with [35S]amino acids (Expre35S35S, New England Nuclear, Bos- 
ton, MA) for the times stated, and chased in the presence of excess unla- 
beled methionine and cysteine. Where indicated, prolonged incubation 
was performed to collect chase media which contained secreted Tg. Tuni- 
camycin, when used, was used at a final concentration of 20 ~g/ml for 3 h 
before labeling (Kim  et  al.,  1992).  Castanospermine was  used  at  the 
maxmimum soluble dose (1.32 raM) for 4 h before labeling. Brefeldin A 
was used at 10 ~g/ml. At the conclusion of each chase period, the cells 
were treated with 50 mM iodoacetamide in ice-cold PBS for 10 min to 
alkylate sulfhydryls intracellularly (Braakman et al.,  1991; Lodish et al., 
1992; Kim et al., 1993). In some experiments, the cells were then lysed di- 
rectly in an SDS-containing buffer. In preparation for two-dimensional 
PAGE, the cells were washed three times in ice-cold PBS and then lysed 
by brief sonication using a sonifier with cup-horn (Branson Ultrasonics 
Corp., Danbury, CT) in 0.5 ml of a solution containing 0.1 M NaC1, 25 mM 
Tris, pH 6.8, 5 mM EDTA, 0.1% Triton X-100, a cocktail of protease in- 
hibitors (0.1 mM leupeptin, 10 mM pepstatin, 1 mM diisopropylfluoro- 
phosphate, 1 mU/ml aprotinin), and 20 U/ml apyrase for 60 min before ad- 
dition of 10 mM iodoacetamide. For experiments in which Tg was to be 
coimmunoprecipitated with GRP94,  thyroid tissue before lysis  was ex- 
posed to alkylating agent plus 0.2 mM disuccinimidyl propionate (Melnick 
et  al.,  1992).  The  cells  were  incubated  in  the  reducible  cross-linker 
(Pierce) for 30 min at 4°C, just before and for 30 min after lysis at 4°C; in 
this case the lysis buffer omitted apyrase. 
Immunoprecipitation 
Equal aliquots of cell lysates were first precleared with Zysorbin or Om- 
nisorb and then immunoprecipitated with each anti-chaperone antibody 
for 2 h at 4°C, before analysis by reducing SDS-PAGE. 
Endoglycosidase H Digestion 
Endo H digestion was performed essentially as previously described (Ar- 
yan and Lee, 1991), using Tg that had been reduced and alkylated after 
SDS denaturation. 
Gel Electrophoresis  and Quantitation 
Reducing, nonreducing SDS-PAGE, and two-dimensional PAGE were 
essentially as previously described (Kim and Arvan, 1991).  In most in- 
stances, before gel loading, samples were normalized either to DNA con- 
tent or to comparable amounts of labeled Tg. Where indicated, the gels 
were dried by conventional methods and visualization and quantitation of 
radiolabeled Tg bands were performed by phosphorimaging coupled to the 
ImageQuant sofware package (Molecular Dynamics, Inc., Sunnyvale, CA). 
Results 
Identification of  Newly Synthesized Mouse Tg 
Tg is the most abundant thyroid protein, representing in 
certain conditions up to 75%  of total glandular protein 
(Van Herle et al., 1979); further, the fraction of new pro- 
tein synthesis devoted to Tg is higher than for any other 
thyroid polypeptide (Wagar, 1974; Dumont et al.,  1989). 
This, coupled with the uniquely high molecular weight of 
N330,000  per  monomer polypeptide,  makes  Tg  readily 
identifiable after amino acid radiolabeling, even without 
immunoprecipitation of cell lysates (see Fig. 8 A, Kim and 
Arvan,  1991)  or secretion  (see  Fig.  1,  Kim and Arvan, 
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mal mice was briefly pulse labeled with [35S]amino acids. 
The  labeled  cellular homogenate was  analyzed by SDS- 
PAGE and phosphorlmaging (Fig. 1, lane 1). Immunopre- 
cipitation  from the  homogenate  with  anti-Tg selectively 
recovered a radiolabeled band of 330,000.  Although a sin- 
gle round of immunoprecipitation recovered only 60--90% 
of this band (see Fig. 1, lane 2), a repeat round of precipi- 
tation with anti-Tg recovered the remaining fraction (lane 3). 
At this time, the supernate representing the cleared homog- 
enate was devoid of labeled N330-kD band, indicating that 
all of the radiolabeled material originally found in the ho- 
mogenate at this  position (lane  1)  was comprised of Tg. 
The  unmistakable  identification,  even without  immuno- 
precipitation, of pulse labeled Tg from mouse thyroid tis- 
sue, greatly accelerated the analysis of subsequent experi- 
ments. 
Quantitative Defect in Tg Production in Thyroid Glands 
from Mutant Mice 
Since cog~cog mice in this study are homozygotes, the poly- 
peptide synthesized from either Tg allele is expected to yield 
an  identical  translation  product.  With  this  in  mind,  we 
compared the  electrophoretic behavior of newly synthe- 
sized Tg from fresh thyroid tissue of normal and cog~cog 
mice after a  brief pulse labeling. The cog~cog thyrocytes 
synthesized a Tg band that precisely comigrated with the 
intact, full-length Tg glycoprotein of normal mice (Fig. 2 A, 
lanes 1 and 3), although when corrected for cell number, 
there was diminution in the intensity of this band. Further, 
when N-linked glycosylation was inhibited by treatment of 
thyroid tissue with tunicamycin, the Tg polypeptide moi- 
ety from cog~cog mice also comigrated with the unglycosy- 
lated version of normal Tg (Fig. 2 A, lanes 2  and 4), indi- 
cating that Tg receives similar N-linked core glycosylation 
Figure  1.  Identification  of 
newly synthesized  mouse Tg 
in thyroid tissue from normal 
mice. Normal mouse thyroid 
tissue  was  pulse-labeled  for 
30 min with [35S]amino acids 
and  lysed  without  chase. 
One-half of the lysate was di- 
luted  into  SDS-gel  sample 
buffer (lysate, lane  1)  and a 
second  half was  exposed to 
anti-Tg for a first (1st IP, lane 
2) and then a second (2nd IP, 
lane 3) round of immunopre- 
cipitation.  One-tenth of each 
of  these  samples  was  ana- 
lyzed  by  4-10%  gradient 
SDS-PAGE, along with one- 
tenth of the remaining super- 
nate  (Sup.,  lane  4)  at  the 
conclusion of the sequential 
immunoprecipitation.  The 
bands  were  visualized  by 
phosphorlmaging. The positions  of molecular weight standards 
are shown at right. 330 k, secreted Tg; 200 k, myosin; 96 k, phos- 
phorylase B. 
Figure 2.  Synthesis and glycosylation of Tg in thyrocytes of nor- 
mal and cog~cog mice. Normal and mutant mouse thyroid tissues 
were pulse-labeled  with  [35S]amino acids  and analyzed  by 4% 
SDS-PAGE and phosphorlmaging after loading for comparable 
amounts of labeled Tg.  Both  tissues  are seen to  contain  full- 
length Tg. (A) Regardless whether pretreated or not pretreated 
with tunicamycin, no difference could be detected for the mobili- 
ties  of glycosylated  (closed arrow) or unglycosylated  (open ar- 
row) Tg between normal (NI) and mutant (Cog) thyrocytes, sug- 
gesting that both sets of Tg receive the same N-linked  glycans. 
(B) Thyroid tissues, pretreated or not pretreated with castano- 
spermine,  were labeled as in (A), and analyzed  by SDS-PAGE 
after immunoprecipitation with anti-Tg. No difference  could be 
detected for the mobilities of glucose trimmed or untrimmed Tg 
between normal (Nl)  and mutant  (Cog) thyrocytes,  indicating 
that both sets of Tg receive the same degree of glucose trimming 
of their N-linked glycans. 
in both cases. Moreover, when glucose trimming of Tg by 
glucosidases I  and II was inhibited with castanospermine 
(Franc et al., 1990), the shift-up in mobility of newly syn- 
thesized  Tg  was  the  same  for  both  normal  and  mutant 
(Fig. 2 B). Thus, not only is Tg from cog~cog mice synthe- 
sized  as  a  full-length  intact  protein,  it  also  undergoes 
N-glycosylation and glucose trimming that is indistinguish- 
able  from normal.  Nevertheless,  upon  subsequent  chase 
for up to 16 h at 37°C, secretion of labeled Tg from mutant 
thyroid tissue was below the limits of detection in our as- 
say (Fig. 3). 
Export of Tg  from the ER to the Distal Secretory 
Pathway Is Inhibited in cog/cog Mice 
Since labeled Tg from the mutant exhibited defective se- 
cretion, we attempted to determine the intracellular loca- 
Figure 3.  Secretion  of Tg from thyrocytes of normal and cog~cog 
mice.  Thyroid tissue  was finely minced  and pulse-labeled  with 
[35S]amino acids as described  in Materials  and Methods.  Upon 
further chase, the labeled Tg released into the medium from bro- 
ken follicles (secreted Tg) was  analyzed  by 4%  reducing  SDS- 
PAGE  and  phosphorlmaging.  Unlike  normal  thyroid  tissue, 
there is no detectable secretion  of newly synthesized Tg from the 
mutant at 4 h or even 16 h chase at 37°C; although this is not an 
ultrasensitive  assay, we did not detect Tg released into the me- 
dium even at our longest exposure. 
Kim et al. Thyroid  ER Storage  Disease  519 tion of this defect. It is well known that upon export to the 
Golgi complex, a subset of the glycans on each Tg mole- 
cule undergoes full Golgi-carbohydrate modification that 
cause these particular glycans to become resistant to diges- 
tion with endo H  (Arvan and Lee, 1991).  Indeed, in nor- 
mal  mouse thyroid tissue  after  a  long pulse  labeling  at 
37°C,  loss  of endo  H  sensitivity was  already  underway 
(Fig. 4 A). In addition, recent studies have shown that con- 
formationally mature Tg has a  high susceptibility to lim- 
ited endoproteolysis in a  short stretch of residues in the 
mature protein sequence that is concentrated immediately 
after position 500 and is hypothesized to represent a physi- 
ologically  relevant  cleavage  region.  Endoproteolysis  in 
this  region  generates  predicted  small  NH2-  and  large 
COOH-terminal fragments (Gentile et al.,  1992;  Gentile 
and Salvatore, 1993) that we have termed Tg-frag  t and Tg- 
flag  2, respectively. Interestingly, as a consequence of fur- 
ther chase  of normal  mouse thyroid tissue  at  37°C,  not 
only did the endo H-sensitive form of Tg decrease, but a 
large radiolabeled Tg fragment was produced that corre- 
sponded  in  size  to  Tg-frag2  (Fig.  4  B);  all  three  forms 
shown were immunoprecipitable with a polyclonal anti-Tg 
(not  shown).  Upon  endoglycosidase  digestion,  Tg-frag2 
underwent a  mobility shift paralleling that  observed for 
endo H-resistant Tg (Fig. 4 B); these data indicate that the 
endoproteolytic cleavage to generate Tg-frag2 occurs after 
Tg export to the Golgi. Consistent with this, we found that 
if, after a long pulse labeling in normal mouse thyroid tis- 
sue, the tissue was then chased in the presence of brefeldin 
A to block further ER export, the endo H-sensitive popu- 
lation of Tg molecules found at the conclusion of the pulse 
(Fig. 4 A) did not shift all the way up to the position of the 
Golgi form during the chase (Fig. 4  C), nor was labeled 
Tg-ffag2 detectable (Fig. 4 C). 
Importantly, in the mutant at 37°C (in the absence of 
brefeldin A), Tg remained essentially completely endo H 
sensitive at chase times up to 4 h, and there was no detect- 
able endoproteolytic production to yield Tg-frag2 (Fig. 4 D). 
We  also manufactured an antibody directed against  the 
highly conserved Tg NH2 terminus, as a means to increase 
the sensitivity for detection of Tg-frag1.2 By Western blot- 
ting (Fig. 5), the band showing the most intense NHE-termi- 
nal immunoreactivity, corresponding to Tg-fragx (Mr ~60- 
65), was detected only in normal but not in mutant mice. 
(As an interesting aside, while a number of higher molecu- 
lar weight immunoreactive Tg fragments overlapped be- 
tween the two specimens, the mutant thyroid reproducibly 
exhibited a smaller NH2-terminal Tg fragment of M~ ~45,000 
that was  not detected in normal thyroid tissue  [asterisk, 
Fig.  5]). Thus, taken together, the  data  strongly suggest 
that in cog~cog mice, the amount of Tg exiting the thyro- 
cyte ER is profoundly inhibited, leading to a markedly de- 
creased fraction of Tg that acquires endo H  resistance or 
undergoes  endoproteolytic cleavage to Tg-frag2 (Fig.  4) 
and Tg-fragl (Fig. 5). 
Tg in cog/cog Mice Exhibits a Temperature-sensitive 
Defect in FoldinglDimerization 
It is now established that the major feature limiting pro- 
tein export from the ER is "quality control", in which un- 
folded and unassembled exportable proteins, recognized 
by structural criteria, are retained and degraded in proxi- 
mal compartments of the secretory pathway (Hammond 
and Helenius, 1995).  To see if quality control might be a 
part of the cog phenotype, we first examined conforma- 
tional maturation of newly synthesized mouse Tg, using a 
two-dimensional PAGE system. With this system it has al- 
ready  been  established  for  cultured  porcine  thyrocytes 
that in the first (native) dimension, unfolded monomers 
migrate as a  broad smear; folded monomers accumulate 
2. Detection of stoichiometric quantities of Tg-fragl by radiolabeling or 
protein staining is more difficult because it contains approximately four- 
fold less incorporated label than Tg-frag2, and is poorly stained with Coo- 
massie blue. 
Figure 4.  Retention of Tg in the ER of cog~cog thyrocytes. Minced thyroid tissue from normal mice, pulse-labeled as in Materials and 
Methods (A), or chased at 37°C for 6 h in the absence (B) or presence of BFA (C), were digested with Endo H, and analyzed by SDS- 
PAGE and phosphorImaging. Endo H-sensitive (ER) and resistant (Golgi) forms of intact Tg, as well as Tg-frag2 (which appears Endo 
H resistant, see text) are shown. In D, minced thyroid tissue from the mutant was pulse-labeled and chased at 37°C without drugs for the 
times indicated. The fraction of newly synthesized Tg that acquired Endo H resistance or endoproteolysis to Tg-frag2 is virtually unde- 
tectable at 37°C. 
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normal  and  mutant  thyroid 
homogenates  with  an  anti- 
body designed  to detect en- 
doproteolytic fragments con- 
taining the Tg NH2 terminus. 
Thyroid  homogenates were 
analyzed  by  8%  reducing 
SDS-PAGE  before transfer 
to  nitrocellulose  for  immu- 
noblotting with the Tg NH  2- 
terminal antibody described 
in the text. A major band of 
Mr  ~60-65,  corresponding 
to  Tg-fragl  (see  text),  was 
detected only in normal thy- 
roid tissue (Nl). By contrast, 
a Tg-fragment of Mr ~45 kD 
(*) was notably increased  only in the mutant (Cog). Full-length 
Tg is not seen in this figure because it fails to transfer from the 
top of the 8% resolving gel under the electrophoretic conditions 
used to  optimally  transfer the fragments.  However, after pro- 
longed transfers of these samples from 4% gels, full-length  Tg 
was  readily  detected  (not shown).  The positions  of molecular 
weight standards are shown at right. 96 k, phosphorylase B; 55 k, 
glutamate dehydrogenase;  35 k, lactate dehydrogenase. 
very little but rapidly assemble to dimers which migrate as 
a discrete spot; and dimers represent the form leaving the 
ER and migrating to the Golgi complex for terminal glyco- 
sylation  (Kim  and  Arvan,  1991;  Kim  et  al.,  1992).  Of 
course, in the second (SDS-PAGE) dimension, essentially 
all Tg runs with similar mobility, on a horizontal line based 
on a monomer molecular weight of ~330,000. 
As shown in the left set of panels of Fig. 6 after 30 min 
of  continuous  radiolabeling,  newly  synthesized  normal 
mouse Tg was distributed over a wide region in the first di- 
mension, indicating a  myriad of unfolded conformational 
states, although there was already detectable formation of 
labeled dimers (closed arrow). After further (0.5 h) chase, 
the  unfolded  forms of Tg were  greatly  attenuated,  and 
augmentation of Tg dimers in the ER was evident. By 1 h, 
a significant portion of Tg dimers had already migrated to 
the Golgi complex, where they underwent a mobility shift 
as a consequence of further carbohydrate processing (open 
arrow).  In the mutant at zero chase, the appearance was 
similar to normal (although  formation of Tg dimers was 
below the  limit  of detection,  Fig.  6,  right  upper panel). 
However, there was dramatic persistence of unfolded Tg, 
such that even at 1 h, labeled Tg dimers were not appreci- 
ated (Fig. 6, right middle panel). Indeed by 2 h, a change in 
distribution appeared to be underway such that labeled Tg 
was accumulating abnormally near the  top of the  native 
gel (arrowhead, right lower panel).  These data suggest that 
a large fraction of newly synthesized Tg in the mutant thy- 
roid fails to attain a normal tertiary and quaternary struc- 
ture. 
Despite the  apparent severity of the  defect, published 
evidence has confirmed that a small fraction of newly syn- 
thesized  Tg is  in  fact exported from the  ER  in  cog~cog 
mice, for two reasons. First, sensitive radiolabeling experi- 
ments  with  1251- in  homozygous mutant  mice have  sug- 
gested  that  a  small  amount  of Tg undergoes  iodination 
Figure 6.  Tg in cog~cog  mice exhibits a defect in tertiary and qua- 
ternary structural  maturation. Cone-down views of two-dimen- 
sional (native/SDS)  PAGE show that after a 30-min pulse, nor- 
mal Tg (Nl) is essentially fully dimeric  by 1 h of chase at 37°C 
(closed arrows) and begins to migrate to the Golgi (open arrow). 
The identities  of ER  and  Golgi  forms of Tg dimer were con- 
firmed by digestion  with endo H. In the mutant (Cog), dimeric 
forms are absent, and by 2 h, the distribution  of Tg shifts towards 
the top of the native dimension  (arrowhead). Radiolabeled Tg 
bands were visualized by phosphorlmaging; exposures of the gels 
in the mutant were increased to enhance sensitivity for the possi- 
ble detection of Tg dimers. 
(Fogelfeld et al., 1992); this covalent modification occurs 
only after Tg export from the ER (Kuliawat and Arvan, 
1994).  Second, analogous to human congenital euthyroid 
goiter (Ohyama et al., 1994), even without treatment with 
exogenous thyroid hormone, cog~cog mice ultimately at- 
tain  normal  blood  concentrations  of  thyroid  hormone 
(Adkison et al., 1990) derived from Tg (Basche et al., 1989). 
Therefore, we can surmise that the Tg defect is not maxi- 
mally severe. Since partial misfolding (e.g., as is found in 
point  mutations  or glycosylation defects)  is  occasionally 
temperature-sensitive (Gibson et al., 1979; Manchester et 
al.,  1994),  we  reexamined Tg export from the  thyrocyte 
ER  at  the  reduced  temperature  of 31°C,  using  a  pulse- 
chase protocol. In this case at 2 h of chase, a readily detect- 
able  (albeit small) fraction of newly synthesized Tg now 
acquired endo H  resistance (Fig. 7). Moreover, by 4 h  of 
chase at 31°C,  the endo H-resistant full-length Tg became 
endoproteolytically converted to Tg-frag2. Although  this 
occurred for only a minority of the labeled Tg population, 
the  evidence indicates  that  cog~cog thyrocytes express  a 
thermosensitive mutant Tg, which diminishes the quantity 
of protein that progresses to a  conformation allowing es- 
cape  from quality  control  regulation,  leading  to  an  ER 
storage disease (ERSD) (Callea et al., 1992). 
Role of Specific ER Chaperones in Quality Control in 
the Thyroid ERSD 
When comparing the overall Coomassie blue-stained pro- 
file of protein extracts from mouse thyroid tissue, in addi- 
tion to intact Tg (present in both normal and mutant thy- 
roid) as well as Tg-frag2 (present only in normals), a group 
of bands  ranging  from  50-100  kD  are  dramatically  en- 
riched in the mutant thyroid (Adkison et al., 1990; and our 
unpublished  observations).  Because ER-specific molecu- 
Kim et al. Thyroid  ER Storage Disease  521 Figure 7.  The defect in cog~cog mice is temperature sensitive. In 
the mutant chased at 31°C for 2 h, a detectable fraction of Tg be- 
comes resistant  to digestion with Endo H (Golgi form). In addi- 
tion, the appearance of Tg-frag2 is subsequently  detectable.  Both 
features indicate  Tg export from the ER. When compared with 
Fig. 4 B, it is evident that for the small fraction of mutant Tg that 
escapes the ER, more of the N-glycans undergo Golgi-type carbo- 
hydrate processing (i.e., less Endo H mobility shift) than for nor- 
mal Tg. This  suggests persistent  structural  differences  between 
the two types of Tg even after ER export. The position of molec- 
ular weight standards  are shown at left. 
lar chaperones  are  thought  to  be quality control factors 
that influence the efficiency of protein export and protein 
degradation,  and because the observed Coomassie bands 
have calculated  molecular masses (,~94,  ~78,  ~72,  ~61, 
and ~58 kD,  [Adkison et al.,  1990;  and our unpublished 
observations])  that  could  be  consistent  with  known  ER 
resident proteins (GRP94, BiP, ERp72, ER60, and calreti- 
culin,  respectively), we  wanted  to  examine more closely 
these  chaperones  that  might  play  a  part  in  physiologic 
compensation  for this  thyroid  ERSD.  For  this  purpose, 
both mutant  and  control mice were treated with full re- 
placement  doses  of  exogenous  thyroid  hormone  in  the 
drinking water for at least 12 wks to minimize any contri- 
bution of hormonal stimulation of the thyroid gland that 
can  alter  ER  chaperone  levels  (Kim and  Arvan,  1993). 
Antibodies (either prepared or obtained against an assort- 
ment of ER resident proteins) were then used for immu- 
noblotting of normal and mutant thyroid tissue samples. 
When normalized to cellular DNA, immunoblotting with 
ECL (Fig. 8 A) could be used to quantitate  the levels of 
ER proteins in thyroid homogenates (Fig. 8  B).  Because 
ER expansion is a known feature of this disease (Mayer- 
hofer et al.,  1988)  and  because the  unfolded  protein re- 
sponse may be coupled to ER biogenesis (Cox et al., 1993), 
it was not  surprising  that  ribophorin  I  (a subunit  of oli- 
gosaccharyl transferase, Kelleher et al., 1992)--known to 
be a reliable marker of ER size (Rajasekaran et al., 1993)--- 
rose 2-2 1/2-fold in cog~cog thyrocytes, while protein disul- 
fide  isomerase  (a  luminal  ER  foldase,  Freedman  et  al., 
1994)  and calnexin (a membrane-bound chaperone, Ou et 
al.,  1993)  were  increased  in  the  same  range  (Fig.  8  B). 
However, in the thyroids of mutant mice, the  concentra- 
tions of a  selective subset of five ER residents increased 
substantially  above this  level (Fig.  8  B).  Indeed,  we  ob- 
served increases in the levels of ER chaperones endoplas- 
min/GPR94 (nearly fivefold), BiP/GRP78 (approximately 
Figure 8.  Accumulation  of ER resident proteins in thyrocytes of 
cog~cog mice includes induction of specific molecular chaperones. 
Thyroid homogenates, normalized to DNA, were examined by 
immunoblotting,  followed by quantitation of specific protein lev- 
els. (A) Antichaperone sera, described in Materials and Methods, 
were  used  for  immunoblotting  with  enhanced  chemilumines- 
cence. (B) Using a minimum of three separate exposures for each 
immunoblot to ensure that linearity of the x-ray film was not ex- 
ceeded, appropriate films were selected for quantitation of band 
intensities  by scanning densitometry.  Quantitation from a mini- 
mum of three different  experiments indicates  that five ER resi- 
dent proteins were induced  5-10-fold  when compared with con- 
trois (error bars, SD). Less dramatic increases were observed in 
PDI, calnexin, and ribophorin I (Rbph I), consistent with a gener- 
alized increase in ER mass. Arb. units: m, NI. m, cog. 
eightfold), and calreticulin (approximately ninefold). More- 
over,  ER60  and  ERp72,  two  proteins  implicated  in  ER 
protein degradation (Urade et al., 1993; Otsu et al., 1995) 
were similarly increased (approximately ninefold and ap- 
proximately tenfold, respectively). Because no increase in 
any of these proteins was seen when comparing other tis- 
sues of mutant and normal mice (data not shown), and the 
elevation of other thyroid ER proteins did not exceed that 
observed for ribophorin I, the data in Fig. 8  B  implicate 
these five ER residents in particular as part of a  specific 
compensatory response to this thyroid ERSD. 
To examine the roles of the ER members of the hsp90 
and hsp70 families, we followed the interaction of newly 
synthesized  Tg with  these  chaperones  by coimmunopre- 
cipitation  after pulse radiolabeling.  As previously estab- 
lished for GRP94, chemical cross-linking was necessary to 
efficiently preserve its  interactions  with  exportable  pro- 
teins  (Melnick  et  al.,  1992;  1994),  although  cross-linking 
was not used for other ER resident proteins (Fig. 9 A). In 
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long-term  association  with  GRP94 and  BiP but  not  calnexin, 
while ERp72 binding shows a novel pattern. (A) For analysis of 
Tg coprecipitation  with  the chaperones,  thyroid homogenates, 
normalized to DNA, were immunoprecipitated  with affinity-puri- 
fied anti-chaperone  antibodies.  Recovery of newly synthesized 
Tg was  analyzed  by reducing  SDS-PAGE and  quantitated  by 
phosphorlmaging.  In the one case of anti-GRP94, thyrocyte pro- 
teins were cross-linked before lysis as described in the Materials 
and Methods.  Direct recoveries  of GRP94,  BiP,  and calnexin 
were all ~>75% by immunoprecipitation,  whereas for ERp72, re- 
covery was <~50%. (B) Pulse-labeled thyrocytes were briefly ex- 
posed to 25 mM D'IT (10 rain) before wash out of the reducing 
agent and lysis as described (Kim and Aryan, 1995). Labeled Tg 
recovered from the whole cell lysate (-) was compared with that 
coprecipitated with anticalnexin (+). Quantitative  Tg coprecipi- 
tation with anticalnexin in normal and mutant thyroid tissue indi- 
cates that in both cases, calnexin and Tg are potentially compati- 
ble binding partners. 
the normal thyroid, the kinetics of dissociation of GRP94 
and BiP was  largely overlapping, declining substantially 
over 60 min of chase. Unlike this, in the mutant, Tg associ- 
ation did not diminish over 2 h. These data correlated closely 
with the kinetics of successful folding in the normal, and 
incomplete folding/homodimerization in the mutant (Fig. 
6).  Such observations are consistent with potential roles 
for GRP94 and BiP, expressed within the physiologic con- 
text, in the inhibition (i.e., quality control) of Tg export 
from the ER (Kim et al., 1992). 
We were also interested to examine calnexin, because 
previous kinetic studies have suggested that most of the 
important interactions of this chaperone with Tg are com- 
pleted during polypeptide translocation into the ER lu- 
men (Kim and Aryan, 1995); thus, one might not expect 
this chaperone to serve a quantitatively significant role in 
quality control of Tg export during the posttranslational 
period. By contrast, this molecule has been proposed to 
serve as a major ER retention factor for certain misfolded 
glycoproteins (Helenius, 1994), because they may be re- 
peatedly reglucosylated (Sousa et al.,  1992) to stimulate 
chaperone association (Hebert et al., 1995). Tg, with 14-22 
N-linked oligosaccharides (Arima et al.,  1972), is  a  well- 
known substrate for the ER deglucosylation/reglucosyla- 
tion cycle (Parodi et al.,  1983); and based on studies  of 
model multiglycosylated proteins, a  large fraction of gly- 
cans undergo this cycle (Ganan et al., 1991).  Such consid- 
erations are especially relevant to the production of Tg in 
cog~cog  thyrocytes, which is misfolded (Fig. 6) yet under- 
goes N-linked glycosylation and glucose trimming compa- 
rable to normal Tg (Fig. 2). Interestingly, Tg in the mutant 
showed  no  augmentation  of  calnexin  association  com- 
pared with normal thyrocytes (Fig. 9 A). Thus, although 
this membrane protein may serve as an important cotrans- 
lational chaperone (Chen et al., 1995; Kim and Arvan, 1995), 
the data does not suggest that calnexin plays a major role 
in the posttranslational ER retention/quality control of Tg 
in mutant thyrocytes. 
A  second function ascribed to ER chaperones is in pro- 
moting proper folding of exportable proteins, as opposed to 
retention/quality control  (Hendershot,  1990;  Kim et  al., 
1992). Based on this view, the foregoing results raised the 
possibility that due to a  subtle primary sequence change 
(such  as  that  causing  absence  of one especially favored 
N-linked oligosaccharide [Ware et al., 1995]), abnormal Tg 
folding might be owed to an inability of Tg to exhibit aug- 
mented binding to calnexin. This seemed unlikely, because 
in three independent studies of the zero chase time, the 
fraction of newly synthesized Tg bound to calnexin in the 
mutant was essentially the same as that seen for the nor- 
mal (data not shown). Nevertheless, to test whether Tg in 
the mutant might be intrinsically deficient in its ability to 
form posttranslational complexes with calnexin, we exam- 
ined this question after exposure of thyrocytes to dithio- 
threitol, since such binding is maximal after in vivo reduc- 
tion of the ER lumen (Kim and Arvan, 1995). Under these 
conditions, newly synthesized Tg in  normal thyroid was 
near-quantitatively associated with calnexin (left, Fig. 9 B). 
This was also true in the mutant (right, Fig. 9 B), suggest- 
ing  that  calnexin  and  Tg  remained  compatible  binding 
partners. 
Finally, we examined the interaction of newly synthe- 
sized Tg with ERp72 (Fig. 9 A, bottom panels). In the nor- 
mal thyroid, immunoprecipitation of ERp72 was found to 
coprecipitate relatively little newly-synthesized Tg at any 
chase time. However, the coprecipitation shown must be 
regarded as an underestimate of the level of interaction, 
since this antibody exhibits a diminished immunoprecipi- 
tation efficiency under the nondenaturing conditions used. 
Despite this, a remarkable increase in specific coprecipita- 
tion of Tg, exclusively in the mutant, was observed as a 
function of chase time. Correlating with the Tg folding ki- 
netics by 2D-PAGE (Fig. 6) these data suggested the pos- 
sibility that  misfolded Tg may accumulate  in  abnormal, 
ERp72-containing complexes after a delay. Thus, based on 
these binding studies (Fig. 9) and previous work (Melnick 
et al., 1994; Kim and Arvan, 1995), at least these four ER 
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simultaneous and sequential manner, and are likely to play 
unique, albeit possibly overlapping roles in quality control 
and protein degradation in the ER. 
Discussion 
ERSDs  (Callea et al.,  1992)  affect numerous organ sys- 
tems, and represent a large group of hereditary and acquired 
diatheses which include subsets of patients with alpha-1- 
antitrypsin deficiency (Sifers et al., 1992), osteogenesis im- 
perfecta (Bonadio and Byers, 1985; Prockop et al., 1985), 
diabetes insipidus (Schmale et al., 1993), a range of bleed- 
ing and clotting disorders (Miura and Aoki, 1990; Miura et 
al., 1993; Tokunaga et al., 1995), and familial hypercholes- 
terolemia as well as others (for review see Amara et al., 
1992).  It is currently thought that ERSDs  are primarily 
protein  folding disorders.  In each instance, the affected 
gene products are deficient in protein trafficking and accu- 
mulate in the ER, where they tend to be degraded (Boni- 
facino  and  Lippincott-Schwartz,  1991). Thus,  these  ill- 
nesses provide unique opportunities to study how quality 
control and ER degradation is regulated by ER chaper- 
ones, which may have evolved to protect cells from poten- 
tially  toxic  accumulation  of  misfolded  proteins  in  the 
secretory pathway. 
In this study, we have examined thyrocytes of homozy- 
gous cog~cog mice,  which like their human counterpart 
(Michel-Bechet et al., 1969; Lissitzky et al., 1975; Ohyama 
et al., 1994) exhibit a grossly distended ER (Beamer et al., 
1987; Mayerhofer et al.,  1988); such cases are new mem- 
bers of the growing family of ERSDs. In cog~cog  mice, the 
ERSD is based on ongoing synthesis of Tg molecules that 
are largely unable to achieve stable homodimers (Fig. 6). 
Nevertheless, mutant mice synthesize a full-length intact 
Tg polypeptide that displays normal N-linked glycosyla- 
tion and glucose trimming (Fig. 2); these processing activi- 
ties occur during or shortly after protein translocation into 
the ER of thyrocytes (Franc et al., 1990) as in other higher 
eukaryotic cells (Gilmore, 1993). However, there is dimin- 
ished secretion of labeled Tg from mutant thyrocytes (Fig. 3) 
and near-quantitative accumulation of new Tg in the ER, 
as confirmed by lack of endo H  resistance or endopro- 
teolytic processing (Figs. 4 and 5). 
At  reduced  temperature,  an  increased fraction of Tg 
does  undergo  transport  through  the  secretory pathway 
(Fig.  7),  consistent with a  temperature-sensitive folding 
defect for mutant Tg. Interestingly, even at body tempera- 
ture, Tg serves as the substrate for synthesis of thyroid 
hormone in mutant mice (Basche et al., 1989; Adkison et 
al.,  1990; Fogelfeld et al.,  1992)  supporting the idea that 
the folding defect for Tg is not maximally severe. Indeed, 
it is possible that for Tg, like for the zIF508-CFTR muta- 
tion  leading to  cystic fibrosis  (another ERSD),  despite 
binding to molecular chaperones (Yang et al.,  1993; Pind 
et al., 1994), a meaningful fraction of ER-entrapped mole- 
cules could be functionally competent (Pasyk and Foskett, 
1995). Thus, an important contribution to the ERSD phe- 
notype may derive from the quality control machinery it- 
self, the stringency of which limits release of exportable 
proteins that have potential biological activity. 
For this reason, we have attempted to examine known 
components of this machinery, comprised primarily of ER 
chaperones. By comparative immunoblotting of wild-type 
and mutant thyrocytes, cellular levels of PDI,  calnexin, 
and ribophorin I are on average ,'~2.3-fold elevated in the 
mutant cells, consistent with a generalized increase in size 
of the ER compartment (Wiest et al., 1990; Rajasekaran et 
al.,  1993). Notably, the relative concentration of PDI in 
the ER is not further increased, consistent with previous 
reports (Macer and Koch, 1988; Dorner et al.,  1990). By 
contrast, five ER luminal chaperones are induced in the 
mutant  cells by an  average  of approximately eighffold, 
suggesting an  >300%  increase in their relative ER con- 
centration (Fig. 8). Despite that these are already among 
the most abundant proteins contained in the normal ER 
(Marquardt et al., 1993), they appear to dominate the en- 
tire mutant thyroid gland (Adkison et al.,  1990; and our 
unpublished observations). We conclude that these partic- 
ular  five  proteins  are  central  to  the  compensatory re- 
sponse to this ERSD. 
One might surmise that the induction of these five chap- 
erones, by itself, increases the efficiency of folding and as- 
sembly of mutant Tg and thereby brings about  a  "self- 
cure". This seems highly unlikely for several reasons. First, 
although helper function of ER chaperones  is  certainly 
possible (Kim et al., 1992; Hammond and Helenius, 1994) 
we  find that  even  in  chaperone-induced  mutant  thyro- 
cytes, Tg export efficiency  falls at or below the limits of de- 
tection (a few percent) in our assays. Second, in the lifespan 
of cog~cog  mice, the induction of chaperones greatly pre- 
cedes the correction of biochemical insufficiency of thy- 
roid  hormone  (our  unpublished  data).  Third,  little  evi- 
dence  currently exists  to  directly demonstrate  that  ER 
chaperones actually assist (except for the catalytic activity 
of PDI [Weissman and Kim, 1993]) in folding of export- 
able proteins (Kim et al.,  1992; Hammond and Helenius, 
1994),  or that elevated levels of ER chaperones can im- 
prove folding or transport efficiency (Dorner et al., 1992). 
In fact, the major physiological response that overcomes 
the genetic defect during the natural history of this illness 
is the increased pituitary secretion of thyroid stimulating 
hormone that causes massive hypertrophy and hyperplasia 
of the thyroid gland (i.e., goiter). Obviously, if the effi- 
ciency of Tg secretion were only 5% of wild-type levels, a 
>20-fold increase in Tg production by an expanded goiter 
could largely correct the problem; moreover, the kinetics 
of growth of the thyroid gland actually parallels or even 
precedes  the recovery of thyroid hormone levels in the 
bloodstream of untreated mutant animals (Adkison et al., 
1990). 
Lowering "free BiP" as a consequence of BiP binding 
induces BiP synthesis (Kohno et al., 1993; Mori et al., 1993). 
From the specific increase in concentrations of other ER 
chaperones, one might be tempted to infer that each of 
these chaperones also physically interacts with misfolded 
Tg. However, while overexpression of individual ER chap- 
erones may not suppress synthesis of others, the promoter 
regions of these five chaperones do exhibit common ele- 
ments, suggesting that group regulation of chaperone syn- 
thesis occurs (Dorner et al., 1990; McCauliffe et al., 1992; 
Srinivasan et al., 1993). Thus, it is still necessary to estab- 
lish the presence of direct interactions of Tg with individ- 
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Kim and Arvan, 1993, 1995). 
In the normal mouse, the interaction of newly synthe- 
sized Tg with BiP exhibits dissociation kinetics  (Fig. 9) 
consistent with a folding pathway for Tg similar to that re- 
ported in porcine cells (Kim et al., 1992; Kim and Arvan, 
1993). The interaction of normal Tg with, and dissociation 
from GRP94 and BiP cannot be resolved by kinetic crite- 
ria (Fig. 9), although we have not yet determined if these 
represent ternary, individual, or even sequential interac- 
tions (Melnick et al.,  1994). Nevertheless, in the mutant, 
the kinetics of these interactions changed such that associ- 
ations with both chaperones were dramatically prolonged 
(Fig. 9). Thus, while it has been shown that both BiP and 
GRP94 can physically interact with Tg (Kuznetsov et al., 
1994),  the present data represent the first demonstration 
that both hsp 70 and hsp 90 family members participate 
significantly in ER retention/quality control of Tg export. 
By contrast, calnexin, whose  interaction with Tg  has 
been  proposed  to  occur  largely cotranslationally rather 
than posttranslationally (Kim and Arvan, 1995),  showed 
no increased binding to Tg in the mutant  vs the normal 
(Fig. 9), lending no support to the idea that this ER mem- 
brane  chaperone plays a  significant role  in posttransla- 
tional ER retention/quality control for Tg. Several factors 
may account for this. First, in agreement with our quanti- 
tative immunoblotting (Fig. 8), the synthesis of calnexin 
has not been found to be especially affected by the un- 
folded protein response (Bergeron et al., 1994). Thus, it is 
expected that, in the face of increasing relative concentra- 
tions of luminal chaperones, the competition for binding 
sites would not favor enhanced calnexin association. Sec- 
ond, surface-to-volume considerations (based on the ge- 
ometry of the  ER  compartment)  suggest  that  calnexin 
might not be  an ideal retention factor for proteins con- 
tained largely in the ER lumen. Third, it is not clear that 
the particular structural information that calnexin binds 
during Tg entrance into the ER is different in normal and 
mutant thyroids. In this regard, despite that calnexin has 
been reported to function as a lectin (Ware et al.,  1995) 
whose interaction is disrupted by inhibition of ER glucosi- 
dases (Hebert et al., 1995), we have found that the interaction 
of calnexin with newly synthesized Tg is essentially inde- 
pendent of N-glycosylation (Kim and Arvan, 1995); more- 
over, castanospermine treatment (Fig. 2) has no effect on 
the coprecipitation of newly synthesized Tg with calnexin 
in either normal or mutant mouse thyroids (our unpub- 
lished data). Fourth, recent evidence has suggested that 
calreticulin may have lectinlike properties  (Wada et al., 
1995; Peterson et al., 1995); unlike calnexin, calreticulin is 
induced significantly in the mutant thyroid (Fig. 8). Thus, 
while we do not favor a lectin interaction of calnexin with 
Tg in the posttranslational period, such an interaction for 
calreticulin is by no means excluded. 
Since accumulation of mutant Tg in the ER is not a le- 
thal condition for thyrocytes, the large fraction of Tg that 
fails to be  exported must be  degraded (Bonifacino and 
Lippincott-Schwartz, 1991). At present, little or nothing is 
known about how Tg is degraded in the mutant thyroid. 
However, as a clue to this process, we note that the distri- 
bution of pulse-labeled Tg  shifts by native  gel  electro- 
phoresis to a position of diminished mobility upon chase 
(Fig. 6). Although the molecular basis for this shift has yet 
to be  determined, such behavior is  compatible with the 
formation of novel Tg-containing complexes en route to 
degradation. With this in mind, we note that exclusively in 
the mutant, as a function of chase time (Fig. 9), there is in- 
creased interaction of Tg with ERp72, one of the proteins 
selectively induced in the thyroids of mutant mice (Fig. 8). 
Indeed, these  association properties  are  consistent with 
possible  involvement of ERp72  in  degrading misfolded 
proteins  or targeting such proteins  for ER degradation 
(Urade et al., 1993) along with ER60, another luminal pro- 
tein (Otsu et al.,  1995)  that is selectively induced in the 
thyroids of mutant mice (Fig. 8). Finally, we note that cog/ 
cog thyrocytes accumulate reasonable quantities of a ~45 
kD NH2-terminal Tg fragment that is not seen in normal 
thyrocytes (Fig.  5),  which may represent  a  partial  pro- 
teolytic product from the ER degradation process. Further 
work will be needed to characterize the degree to which 
each ER chaperone influences the fate of Tg and other 
secretory proteins in normal cells and in ERSDs. 
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